FMP
NASDAQ
2.02 USD
-0.06 (-2.97%)
Ms. Maria Zannes J.D.
Healthcare
Diagnostics & Research
https://www.bioaffinitytech.com
NASDAQ
bioAffinity Technologies, Inc., a biotechnology company, engages in developing non-invasive diagnostic tests and targeted cancer therapeutics. The company offers CyPath lung, a diagnostic test, for early detection of lung cancer. It also researches targeted therapies to treat cancer at the cellular level. The company was founded in 2014 and is based in San Antonio, Texas.
0001712762
US09076W1099
N/A
22211 West Interstate 10
210 698 5334
US
14
Sep 1, 2022